What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era

Smith, Sally A.; Juggins, A. D.; Evans, Scott E.; Pilkington, C

doi:10.1186/1546-0096-6-s1-p218

Pediatr Rheumatol

2008

DOI: 10.1186/1546-0096-6-s1-p218

|View full text |Cite

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era

Sally A. Smith¹,

A. D. Juggins²,

Scott E. Evans³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2012

Publication Types

Select...

Book1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Juvenile Dermatomyositis

Wedderburn¹

2012

Textbook of Clinical Pediatrics

View full text Add to dashboard Cite

the subgroups of patients with JIA. The mean (SD) antibody levels in the children with JIA were significantly lower (175.5 (118.4) mIU/ ml) than those of the healthy subjects (317.08 (180.5) mIU/ml) There was no diVerence between the sexes in vaccine responsiveness. When the antibody levels between the two vaccination schedules were compared in healthy children, there was no statistical diVerence. However, there was a slightly higher, but statistically insignificant, response in JIA subjects vaccinated in group II than in those in group I. The vaccine responsiveness was not influenced either by methotrexate or prednisolone treatment. However, there was a negative correlation between prednisolone dose and anti-HBs titre (r=−0.23). Conclusion-Children with JIA responded adequately to hepatitis B vaccination, and this response was not negatively influenced by immunosuppressive treatment. The more appropriate vaccination schedule for children with JIA is the schedule given at 0, 1, and 6 months.

show abstract

Juvenile Dermatomyositis

Wedderburn¹

2012

Textbook of Clinical Pediatrics

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era

Cited by 1 publication

References 0 publications

Juvenile Dermatomyositis

Juvenile Dermatomyositis

Contact Info

Product

Resources

About